Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
34. Hoskins PJ, Swenerton KD: Oral etoposide is active against platinum-resistant<br />
epithelial ovarian cancer. J Clin Oncol 1994; 12 (1): 60-3.<br />
35. Rose PG, Blessing JA, Mayer AR, et al.: Prolonged oral etoposide as second-line<br />
therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic<br />
Oncology Group study. J Clin Oncol 1998; 16 (2): 405-10.<br />
36. Friedlander M, Millward MJ, Bell D, et al.: A phase II study of gemcitabine in<br />
platinum pre-treated patients with advanced epithelial ovarian cancer. Ann Oncol 1998; 9<br />
(12): 1343-5.<br />
37. Shapiro JD, Millward MJ, Rischin D, et al.: Activity of gemcitabine in patients with<br />
advanced ovarian cancer: responses seen following platinum and paclitaxel. Gynecol<br />
Oncol 1996; 63 (1): 89-93.<br />
38. Hatch KD, Beecham JB, Blessing JA, Creasman WT. Responsiveness of patients with<br />
advanced ovarian carcinoma to tamoxifen. A Gynecologic Oncology Group study of<br />
second-line therapy in 105 patients. Cancer 1991: 68 (2): 269-71.<br />
39. Kaern J, Tropé CG, Abeler VM: A retrospective study of 370 borderline tumors of the<br />
ovary treated at the Norwegian Radium Hospital from 1970 to 1982. A review of<br />
clinicopathologic features and treatment modalities. Cancer 1993: 71 (5): 1810-20.<br />
40. Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. Behavior of borderline<br />
tumors with particular interest to persistence, recurrence, and progression to invasive<br />
carcinoma: a prospective study. J Clin Oncol 2001: 19 (10): 2658-64.<br />
41. Tropé C, Kaern J, Vergote I, Kristensen G, Abeler V. Are borderline tumors of the<br />
ovary overtreated both surgically and systemically? A review of four prospective<br />
randomized trials including 253 patients with borderline tumors. Gynecol Oncol 1993: 51<br />
(2): 236-43.<br />
42. Schumer ST, Cannistra SA. Granulosa cell tumors of the ovary. J Clin Oncol. 2003; 21<br />
(6): 1180-9.<br />
43. Williams S, Blessing JA, Liao SY, Ball H, Hanjani P. Adjuvant therapy of ovarian<br />
germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic<br />
Oncology Group. J Clin Oncol 1994: 12 (4): 701-6.<br />
44. Slayton RE, Park RC, Silverberg SG, Shingleton H, Creasman WT, Blessing JA.<br />
Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell<br />
tumors of the ovary. A Gynecologic Oncology Group Study (a final report). Cancer 1985:<br />
56 (2): 243-8.<br />
45. Gershenson DM. Update on malignant ovarian germ-cell tumors. Cancer 1993; 71 (4<br />
suppl): 1581-90.<br />
46. Gershenson DM, Morris M, Cangir A, Kavanagh JJ, Stringer CA, Edwards CL.<br />
Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and<br />
cisplatin. J Clin Oncol 1990: 8 (4): 715-20.<br />
47. William SD, Blessing JA, DiSaia PJ, Major FJ, Ball HG 3rd, Liao SY. Second look<br />
laparotomy in ovarian germ cell tumors: the gynecologic oncology group experience.<br />
Gynecol Oncol 1994 Mar; 52 (3): 287-91.<br />
96
Change language